Literature DB >> 12164297

The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions.

Diana N J Lockwood1, M J Colston, S R Khanolkar-Young.   

Abstract

Type 1 (reversal) reactions are the most common immunological complications of leprosy. These episodes of delayed hypersensitivity produce severe local immunopathology and ultimately nerve damage. To date, the Mycobacterium leprae antigens associated with type 1 reactions have not been identified. Using monoclonal antibodies to defined protein and carbohydrate M. leprae epitopes (65, 35 and 28 kd and lipoarabinomannan [LAM]) in a two-step immunoperoxidase staining technique, M. leprae antigens were demonstrated in skin and nerve biopsies from patients in reversal reaction. Antigen presence and staining patterns were similar in skin and nerve lesions, implying that the pathological processes are similar in the two sites. Antigens were present both in macrophages and Schwann cells but also as a diffuse extracellular infiltrate associated with the inflammatory infiltrate. The 28-kd antigen was present most strongly and may be a potential candidate antigen for initiating type 1 reactions. LAM also stained strongly and persisted after treatment. The possible roles of LAM and 65 kd in the cellular events of type 1 reactions are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164297     DOI: 10.4269/ajtmh.2002.66.409

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Transcriptional changes that characterize the immune reactions of leprosy.

Authors:  Kathryn M Dupnik; Thomas B Bair; Andressa O Maia; Francianne M Amorim; Marcos R Costa; Tatjana S L Keesen; Joanna G Valverde; Maria do Carmo A P Queiroz; Lúcio L Medeiros; Nelly L de Lucena; Mary E Wilson; Mauricio L Nobre; Warren D Johnson; Selma M B Jeronimo
Journal:  J Infect Dis       Date:  2014-11-14       Impact factor: 5.226

2.  Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1.

Authors:  Claudia Manca; Blas Peixoto; Wladimir Malaga; Christophe Guilhot; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2011-10-07       Impact factor: 2.607

3.  Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.

Authors:  Sundeep Chaitanya; Mallika Lavania; Ravindra P Turankar; Samuel Raj Karri; U Sengupta
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

4.  Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.

Authors:  Rupendra Jadhav; Lavanya Suneetha; Ravindra Kamble; Vidyagouri Shinde; Karuna Devi; Meher Vani Chaduvula; Renuka Raju; Sujai Suneetha; Peter G Nicholls; Wim H van Brakel; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

5.  In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.

Authors:  Nawal Bahia El Idrissi; Anand M Iyer; Valeria Ramaglia; Patricia S Rosa; Cleverson T Soares; Frank Baas; Pranab K Das
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

6.  A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.

Authors:  Saba M Lambert; Digafe T Alembo; Shimelis D Nigusse; Lawrence K Yamuah; Stephen L Walker; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2016-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.